DiagnaMed Files U.S. Patent Application for Novel Methods of Producing Molecular Hydrogen
07. November 2024 08:00 ET
|
DiagnaMed Holdings Corp.
Advancing molecular hydrogen for neurological and mental health disorders Expects its molecular hydrogen product to be ready for use in December 2024 TORONTO, Nov. 07, 2024 (GLOBE NEWSWIRE) --...
DiagnaMed Advancing the Medical Potential of Hydrogen
30. Oktober 2024 08:00 ET
|
DiagnaMed Holdings Corp.
TORONTO, Oct. 30, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a life sciences company focused on brain health, announces its...